Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envarsus XR vs Tacrolimus in Kidney Transplant
NCT03321656Phase 3Recruiting
- Start
- Mar 2019
- Primary completion
- Mar 2027
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tacrolimus in end stage renal disease (ESRD). Started Mar 2019; status: recruiting.
02
Drugs
tacrolimus
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT03321656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03321656.